ability	NN	ability
of	IN	of
cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
amniotic	JJ	amniotic
membrane	NN	membrane
.	SENT	.
groups	NNS	group
of	IN	of
population	NN	population
.	SENT	.
CRPS	NP	INFunknownSUP
patients.The	JJ	INFunknownSUP
.	SENT	.
non-white	JJ	non-white
dialysis	NN	dialysis
patients	NNS	patient
different	JJ	different
biochemical	JJ	biochemical
parameters	NNS	parameter
.	SENT	.
myosine	NN	INFunknownSUP
expression	NN	expression
.	SENT	.
odds	NNS	odd
ratio	NN	ratio
.	SENT	.
oral	JJ	oral
mucosa	NN	mucosa
.	SENT	.
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
elderly	JJ	elderly
people	NNS	people
.	SENT	.
different	JJ	different
biochemical	JJ	biochemical
parameters	NNS	parameter
.	SENT	.
superior	JJ	superior
rectus	NN	rectus
.	SENT	.
small	JJ	small
intestine	NN	intestine
.	SENT	.
therapy	NN	therapy
targets	NNS	target
.	SENT	.
fluid	NN	fluid
of	IN	of
artificial	JJ	artificial
skin	NN	skin
blisters	NNS	blister
.	SENT	.
rat	NN	rat
tendon	NN	tendon
.	SENT	.
vivo	JJ	vivo
mouse	NN	mouse
model	NN	model
.	SENT	.
provoking	JJ	provoking
cardiac	JJ	cardiac
events	NNS	event
.	SENT	.
burst	NN	burst
spinal	JJ	spinal
cord	NN	cord
stimulation	NN	stimulation
.	SENT	.
healthy	JJ	healthy
controls	NNS	control
.	SENT	.
appropriate	JJ	appropriate
therapeutic	JJ	therapeutic
effect	NN	effect
.	SENT	.
background	NN	background
of	IN	of
standard	JJ	standard
therapy	NN	therapy
.	SENT	.
considerable	JJ	considerable
promise	NN	promise
.	SENT	.
cardiotropic	JJ	INFunknownSUP
potential	NN	potential
.	SENT	.
various	JJ	various
diseases	NNS	disease
.	SENT	.
levels	NNS	level
of	IN	of
cytokines	NNS	INFunknownSUP
.	SENT	.
growth	NN	growth
factors	NNS	factor
.	SENT	.
useful	JJ	useful
predictors	NNS	predictor
of	IN	of
long-term	JJ	long-term
survival	NN	survival
.	SENT	.
A.Severe	NP	INFunknownSUP
burn	NN	burn
.	SENT	.
acute	JJ	acute
inflammatory	JJ	inflammatory
response	NN	response
.	SENT	.
important	JJ	important
findings	NNS	finding
.	SENT	.
SCS	NP	INFunknownSUP
treatment	NN	treatment
.	SENT	.
relevant	JJ	relevant
subtypes	NNS	subtype
.	SENT	.
steroids.Multimodal	JJ	INFunknownSUP
imaging	NN	imaging
.	SENT	.
airflow	NN	airflow
obstruction	NN	obstruction
.	SENT	.
expression	NN	expression
of	IN	of
inflammatory	JJ	inflammatory
mediators	NNS	mediator
.	SENT	.
Anti-Inflammatory	JJ	anti-inflammatory
Therapeutics	NNS	therapeutics
.	SENT	.
cardiovascular	JJ	cardiovascular
system	NN	system
.	SENT	.
gender-matched	JJ	INFunknownSUP
healthy	JJ	healthy
persons	NNS	person
.	SENT	.
noncardiovascular	JJ	INFunknownSUP
mortality	NN	mortality
.	SENT	.
system	NN	system
activation	NN	activation
.	SENT	.
call	NN	call
to	TO	to
action	NN	action
.	SENT	.
host	NN	host
receptors	NNS	receptor
.	SENT	.
part	NN	part
of	IN	of
the	DT	the
small	JJ	small
intestine	NN	intestine
.	SENT	.
A2AR-knockout	NP	INFunknownSUP
mice	NNS	mouse
.	SENT	.
coronary	JJ	coronary
intervention	NN	intervention
.	SENT	.
substantial	JJ	substantial
alteration	NN	alteration
of	IN	of
the	DT	the
gut	NN	gut
microbiota	NN	INFunknownSUP
composition	NN	composition
.	SENT	.
association	NN	association
of	IN	of
inflammation	NN	inflammation
.	SENT	.
Creative	NP	Creative
Commons	NP	Commons
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
Derivatives	NP	INFunknownSUP
License	NP	License
4.0	NP	4.0
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
NEOVASCULARIZATION	NP	INFunknownSUP
ASSOCIATED	NP	Associated
WITH	NP	INFunknownSUP
FOCAL	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
.	SENT	.
non-white	JJ	non-white
chronic	JJ	chronic
dialysis	NN	dialysis
patients	NNS	patient
.	SENT	.
inflammatory	JJ	inflammatory
consequences	NNS	consequence
of	IN	of
biota	NN	biota
depletion	NN	depletion
.	SENT	.
young	JJ	young
WT	NP	INFunknownSUP
mice	NNS	mouse
.	SENT	.
long-term	JJ	long-term
pioglitazone	NN	INFunknownSUP
intake	NN	intake
.	SENT	.
T.Digital	JJ	INFunknownSUP
quantitative	JJ	quantitative
analysis	NN	analysis
of	IN	of
mast	NN	mast
cell	NN	cell
infiltration	NN	infiltration
.	SENT	.
%	NN	%
total	JJ	total
body	NN	body
surface	NN	surface
area	NN	area
scald	NN	scald
burn	NN	burn
.	SENT	.
intake	NN	intake
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
amniotic	JJ	amniotic
membrane	NN	membrane
.	SENT	.
gut	NN	gut
microbiota	NN	INFunknownSUP
.	SENT	.
strabismus	NN	strabismus
surgery	NN	surgery
.	SENT	.
biota	NN	biota
depletion	NN	depletion
.	SENT	.
M.	NP	M.
tuberculosis	NN	tuberculosis
.	SENT	.
diastolic	JJ	diastolic
blood	NN	blood
pressure	NN	pressure
.	SENT	.
macrophage-mediated	JJ	INFunknownSUP
neutrophil	JJ	neutrophil
recruitment	NN	recruitment
.	SENT	.
months	NNS	month
of	IN	of
burst	NN	burst
SCS	NP	INFunknownSUP
treatment	NN	treatment
.	SENT	.
unpredictable	JJ	unpredictable
course	NN	course
of	IN	of
disease	NN	disease
.	SENT	.
special	JJ	special
immunological	JJ	immunological
profile	NN	profile
.	SENT	.
experimental	JJ	experimental
strabismus	NN	strabismus
surgery	NN	surgery
.	SENT	.
markers	NNS	marker
of	IN	of
innate	JJ	innate
immunity	NN	immunity
.	SENT	.
SR	NN	SR
muscle	NN	muscle
.	SENT	.
AM	NP	AM
allograft	NN	INFunknownSUP
.	SENT	.
antiarrhytmic	JJ	INFunknownSUP
properties	NNS	property
.	SENT	.
non-/pre-obese	JJ	INFunknownSUP
chronic	JJ	chronic
back	JJ	back
pain	NN	pain
patients	NNS	patient
.	SENT	.
Mast	NN	Mast
cell	NN	cell
.	SENT	.
type	NN	type
IC	NP	IC
.	SENT	.
clinical	JJ	clinical
scientists	NNS	scientist
.	SENT	.
dorsal	JJ	dorsal
air	NN	air
pouches	NNS	pouch
.	SENT	.
alteration	NN	alteration
of	IN	of
the	DT	the
gut	NN	gut
microbiota	NN	INFunknownSUP
composition	NN	composition
.	SENT	.
neutrophil	JJ	neutrophil
viability	NN	viability
.	SENT	.
adoption	NN	adoption
of	IN	of
the	DT	the
new	JJ	new
definition	NN	definition
.	SENT	.
heart	NN	heart
disease	NN	disease
.	SENT	.
novel	NN	novel
mechanisms	NNS	mechanism
.	SENT	.
basic	JJ	basic
therapeutic	JJ	therapeutic
capabilities	NNS	capability
.	SENT	.
Vitamin	NN	vitamin
D	NP	D
.	SENT	.
modern	JJ	modern
therapy	NN	therapy
.	SENT	.
course	NN	course
of	IN	of
standard	JJ	standard
therapies	NNS	therapy
.	SENT	.
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
Derivatives	NP	INFunknownSUP
License	NP	License
4.0	NP	4.0
.	SENT	.
immune	JJ	immune
response	NN	response
.	SENT	.
degree	NN	degree
of	IN	of
postoperative	JJ	postoperative
inflammatory	JJ	inflammatory
infiltration	NN	infiltration
.	SENT	.
positive	JJ	positive
indicators	NNS	indicator
of	IN	of
RI	NP	RI
.	SENT	.
therapeutic	JJ	therapeutic
use	NN	use
.	SENT	.
clinical	JJ	clinical
features	NNS	feature
.	SENT	.
AKI	NP	Aki
provoking	JJ	provoking
cardiac	JJ	cardiac
events	NNS	event
.	SENT	.
neuron	NN	neuron
disease	NN	disease
.	SENT	.
histology-intravascular	JJ	INFunknownSUP
ultrasound	NN	ultrasound
.	SENT	.
healthy	JJ	healthy
persons	NNS	person
.	SENT	.
regard	NN	regard
to	TO	to
the	DT	the
overall	JJ	overall
number	NN	number
of	IN	of
microbial	JJ	microbial
species	NNS	specie
.	SENT	.
Achilles	NP	Achilles
tendon	NN	tendon
.	SENT	.
predictors	NNS	predictor
of	IN	of
long-term	JJ	long-term
survival	NN	survival
.	SENT	.
T.Severe	NP	INFunknownSUP
Burn-Induced	NP	INFunknownSUP
.	SENT	.
standard	JJ	standard
therapy	NN	therapy
.	SENT	.
choroidal	JJ	INFunknownSUP
inflammation.Case	NN	INFunknownSUP
report.A	NN	INFunknownSUP
.	SENT	.
greater	JJR	great
risk	NN	risk
of	IN	of
cancer	NN	cancer
.	SENT	.
cardiovascular	JJ	cardiovascular
mortality	NN	mortality
.	SENT	.
Forty	NN	forty
male	JJ	male
Sprague-Dawley	NP	INFunknownSUP
rats	NNS	rat
.	SENT	.
myocardial	JJ	myocardial
contractility	NN	contractility
.	SENT	.
%	NN	%
confidence	NN	confidence
interval	NN	interval
.	SENT	.
ASSOCIATED	NP	Associated
WITH	NP	INFunknownSUP
.	SENT	.
acute	JJ	acute
kidney	NN	kidney
injury	NN	injury
.	SENT	.
scientists	NNS	scientist
of	IN	of
a	DT	a
helminth	NN	helminth
.	SENT	.
noninvasive	JJ	noninvasive
ventilation	NN	ventilation
.	SENT	.
Multivariate	JJ	multivariate
analysis	NN	analysis
.	SENT	.
interstitial	JJ	interstitial
cystitis	NN	cystitis
.	SENT	.
leukocyte	NN	INFunknownSUP
count	NN	count
.	SENT	.
entire	JJ	entire
lamina	NN	lamina
propria	NN	INFunknownSUP
.	SENT	.
coronary	JJ	coronary
heart	NN	heart
disease	NN	disease
.	SENT	.
biological	JJ	biological
processes	NNS	process
.	SENT	.
cord	NN	cord
stimulation	NN	stimulation
.	SENT	.
genuine	JJ	genuine
markers	NNS	marker
of	IN	of
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
non-IC	JJ	INFunknownSUP
control	NN	control
specimens	NNS	specimen
.	SENT	.
subclinical	JJ	subclinical
disease	NN	disease
.	SENT	.
gastrointestinal	JJ	gastrointestinal
tract	NN	tract
.	SENT	.
past	JJ	past
CRPS	NP	INFunknownSUP
studies	NNS	study
.	SENT	.
issue	NN	issue
of	IN	of
modern	JJ	modern
therapy	NN	therapy
.	SENT	.
possible	JJ	possible
immunomodulatory	JJ	INFunknownSUP
effects	NNS	effect
of	IN	of
SCS	NP	INFunknownSUP
.	SENT	.
chronic	JJ	chronic
heart-kidney	NN	INFunknownSUP
cross	NN	cross
talk	NN	talk
.	SENT	.
routine	JJ	routine
medical	JJ	medical
check-ups	NNS	check-up
.	SENT	.
ALS	JJ	INFunknownSUP
patients	NNS	patient
.	SENT	.
T.Digital	JJ	INFunknownSUP
quantitative	JJ	quantitative
analysis	NN	analysis
.	SENT	.
T.CLINICAL	NP	INFunknownSUP
COURSE	NP	Course
.	SENT	.
C-type	NP	INFunknownSUP
lectin	NN	INFunknownSUP
receptors	NNS	receptor
.	SENT	.
exposure	NN	exposure
to	TO	to
a	DT	a
cocktail	NN	cocktail
of	IN	of
proinflammatory	JJ	INFunknownSUP
cytokines	NNS	INFunknownSUP
.	SENT	.
fatal	JJ	fatal
human	JJ	human
infectious	JJ	infectious
disease	NN	disease
.	SENT	.
stability	NN	stability
maintenance	NN	maintenance
.	SENT	.
neutrophil	JJ	neutrophil
influx	NN	influx
.	SENT	.
culprit	NN	culprit
lesion	NN	lesion
.	SENT	.
musculoskeletal	JJ	musculoskeletal
system	NN	system
.	SENT	.
hypothesis	NN	hypothesis
of	IN	of
a	DT	a
link	NN	link
.	SENT	.
beginning	NN	beginning
of	IN	of
the	DT	the
large	JJ	large
intestine	NN	intestine
.	SENT	.
MicroRNA	NP	INFunknownSUP
target	NN	target
prediction	NN	prediction
.	SENT	.
CXCL1-3	NP	INFunknownSUP
levels	NNS	level
.	SENT	.
combination	NN	combination
of	IN	of
vascular	JJ	vascular
damage	NN	damage
inflammation	NN	inflammation
.	SENT	.
image	NN	image
analysis	NN	analysis
software	NN	software
.	SENT	.
coronary	JJ	coronary
angiography	NN	angiography
.	SENT	.
HF	NP	HF
patients	NNS	patient
.	SENT	.
heat-killed	JJ	INFunknownSUP
M.	NP	M.
tuberculosis	NN	tuberculosis
H37Ra	NP	INFunknownSUP
.	SENT	.
lymphoplasmacytic	JJ	INFunknownSUP
cell	NN	cell
.	SENT	.
monocyte	NN	monocyte
counts	NNS	count
.	SENT	.
FEV1	JJ	INFunknownSUP
performance	NN	performance
.	SENT	.
target	NN	target
prediction	NN	prediction
.	SENT	.
non-obese	JJ	INFunknownSUP
chronic	JJ	chronic
back	JJ	back
pain	NN	pain
patients	NNS	patient
.	SENT	.
therapeutic	JJ	therapeutic
effect	NN	effect
.	SENT	.
WT	NP	INFunknownSUP
mice	NNS	mouse
.	SENT	.
muscle	NN	muscle
loss	NN	loss
.	SENT	.
mast	NN	mast
cell	NN	cell
count	NN	count
.	SENT	.
vitamin	NN	vitamin
d	NN	d
.	SENT	.
transient	JJ	transient
etoposide	NP	etoposide
treatment	NN	treatment
.	SENT	.
growth	NN	growth
factor-beta-1(TGFβ-1	NN	INFunknownSUP
.	SENT	.
NHEJ-mediated	JJ	INFunknownSUP
DNA	NN	DNA
repair	NN	repair
.	SENT	.
Ku70/Ku80/DNA-PKcs	NP	INFunknownSUP
complex	NN	complex
.	SENT	.
chronic	JJ	chronic
systemic	JJ	systemic
conditions	NNS	condition
.	SENT	.
much	JJ	much
attention	NN	attention
.	SENT	.
weakened	JJ	weakened
Ku80/DNA-PKcs	NP	INFunknownSUP
interaction	NN	interaction
.	SENT	.
new	JJ	new
diagnostic	JJ	diagnostic
methods	NNS	method
.	SENT	.
baseline	JJ	baseline
demographics	NNS	demographic
.	SENT	.
metabolic	JJ	metabolic
state	NN	state
.	SENT	.
phosphorus	NN	phosphorus
homeostasis	NN	homeostasis
.	SENT	.
systolic	JJ	systolic
blood	NN	blood
pressure	NN	pressure
.	SENT	.
large	JJ	large
part	NN	part
.	SENT	.
Associated	NP	Associated
Peripheral	NP	INFunknownSUP
.	SENT	.
Significant	JJ	significant
differences	NNS	difference
.	SENT	.
chronic	JJ	chronic
cystitis	NN	cystitis
.	SENT	.
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
.	SENT	.
anti-inflammatory	JJ	anti-inflammatory
IL-10	NP	INFunknownSUP
.	SENT	.
SR	NN	SR
resection	NN	resection
.	SENT	.
current	JJ	current
study	NN	study
.	SENT	.
diameter	NN	diameter
increase	NN	increase
.	SENT	.
MSC-based	JJ	INFunknownSUP
therapy	NN	therapy
.	SENT	.
blood	NN	blood
flow	NN	flow
velocity	NN	velocity
.	SENT	.
Picrosirius	NP	INFunknownSUP
red	NN	red
.	SENT	.
pathway	NN	pathway
delays	NNS	delay
.	SENT	.
episodes	NNS	episode
of	IN	of
remission	NN	remission
.	SENT	.
local	JJ	local
levels	NNS	level
of	IN	of
cytokines	NNS	INFunknownSUP
.	SENT	.
white	JJ	white
patients	NNS	patient
.	SENT	.
differential	JJ	differential
diagnosis	NN	diagnosis
.	SENT	.
large	JJ	large
intestine	NN	intestine
.	SENT	.
normal	JJ	normal
range	NN	range
.	SENT	.
pain	NN	pain
syndrome	NN	syndrome
.	SENT	.
biochemical	JJ	biochemical
parameters	NNS	parameter
.	SENT	.
clinical	JJ	clinical
course	NN	course
of	IN	of
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
.	SENT	.
non-Hunner	NP	INFunknownSUP
type	NN	type
IC	NP	IC
.	SENT	.
blood	NN	blood
pressure	NN	pressure
.	SENT	.
variety	NN	variety
of	IN	of
biological	JJ	biological
processes	NNS	process
.	SENT	.
kidney	NN	kidney
function	NN	function
.	SENT	.
comparable	JJ	comparable
cytokine	NN	INFunknownSUP
pattern	NN	pattern
.	SENT	.
C-reactive	JJ	INFunknownSUP
protein	NN	protein
.	SENT	.
lymphoplasmacytic	JJ	INFunknownSUP
cell	NN	cell
densities	NNS	density
.	SENT	.
neutrophil	JJ	neutrophil
recruitment	NN	recruitment
.	SENT	.
response	NN	response
to	TO	to
infection	NN	infection
.	SENT	.
SSc	NP	INFunknownSUP
diagnosis	NN	diagnosis
.	SENT	.
levels	NNS	level
of	IN	of
high-sensitivity	NN	INFunknownSUP
C-reactive	JJ	INFunknownSUP
protein	NN	protein
.	SENT	.
endothelium	NN	endothelium
protective	JJ	protective
effects	NNS	effect
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
complex	JJ	complex
therapy	NN	therapy
.	SENT	.
angular	JJ	angular
cheilitis	NN	INFunknownSUP
.	SENT	.
production	NN	production
of	IN	of
CXCL8	NP	INFunknownSUP
.	SENT	.
necrotic	JJ	necrotic
core	NN	core
volume	NN	volume
.	SENT	.
functional	JJ	functional
changes	NNS	change
.	SENT	.
markers	NNS	marker
of	IN	of
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
Mast	NN	Mast
cell	NN	cell
density	NN	density
.	SENT	.
IL-1α	NP	INFunknownSUP
decreasing.ConclusionAging	NN	INFunknownSUP
.	SENT	.
multisystem	NN	INFunknownSUP
disorder	NN	disorder
of	IN	of
the	DT	the
connective	JJ	connective
tissue	NN	tissue
.	SENT	.
Hz	NP	hz
standard	JJ	standard
frequency	NN	frequency
stimulation	NN	stimulation
.	SENT	.
indicators	NNS	indicator
of	IN	of
RI	NP	RI
.	SENT	.
mast	NN	mast
cell	NN	cell
densities	NNS	density
.	SENT	.
FC	NP	FC
II	NP	II
.	SENT	.
infections	NNS	infection
of	IN	of
cardiotropic	JJ	INFunknownSUP
potential	NN	potential
.	SENT	.
operational	JJ	operational
taxonomic	JJ	taxonomic
units	NNS	unit
.	SENT	.
rabbit	NN	rabbit
model	NN	model
of	IN	of
strabismus	NN	strabismus
surgery	NN	surgery
.	SENT	.
16S	JJ	INFunknownSUP
rRNA	NN	INFunknownSUP
gene	NN	gene
.	SENT	.
vascular	JJ	vascular
damage	NN	damage
inflammation	NN	inflammation
.	SENT	.
frequency	NN	frequency
of	IN	of
angina	NN	angina
FC	NP	FC
I	NP	I
.	SENT	.
Gene	NN	gene
expression	NN	expression
of	IN	of
IL-6	NP	INFunknownSUP
.	SENT	.
inflammatory	JJ	inflammatory
changes	NNS	change
.	SENT	.
sudomotor	NN	INFunknownSUP
disturbances	NNS	disturbance
.	SENT	.
normal	JJ	normal
bladder	NN	bladder
specimens	NNS	specimen
.	SENT	.
function	NN	function
of	IN	of
caspase-2	NN	INFunknownSUP
.	SENT	.
area	NN	area
scald	NN	scald
burn	NN	burn
.	SENT	.
plaque	NN	plaque
composition	NN	composition
.	SENT	.
pathogenesis	NN	pathogenesis
of	IN	of
disorder	NN	disorder
.	SENT	.
kynurenine	NN	INFunknownSUP
pathway	NN	pathway
.	SENT	.
immunomodulatory	JJ	INFunknownSUP
effects	NNS	effect
of	IN	of
SCS	NP	INFunknownSUP
.	SENT	.
lymphoplasmacytic	JJ	INFunknownSUP
cells	NNS	cell
.	SENT	.
HC).Mean	NP	INFunknownSUP
BMI	NP	BMI
.	SENT	.
diameter	NN	diameter
of	IN	of
the	DT	the
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
setting	NN	setting
of	IN	of
choroidal	JJ	INFunknownSUP
inflammation	NN	inflammation
.	SENT	.
cellular	JJ	cellular
Therapy	NN	therapy
.	SENT	.
European	NP	European
League	NP	League
.	SENT	.
Optimal	JJ	optimal
vitamin	NN	vitamin
D	NP	D
serum	NN	serum
concentration	NN	concentration
.	SENT	.
different	JJ	different
ages.Several	JJ	INFunknownSUP
readouts	NNS	readout
.	SENT	.
involvement	NN	involvement
of	IN	of
the	DT	the
immune	JJ	immune
system	NN	system
.	SENT	.
manifestation	NN	manifestation
of	IN	of
this	DT	this
disease	NN	disease
.	SENT	.
heat-killed	JJ	INFunknownSUP
M.	NP	M.
tuberculosis	NN	tuberculosis
H37Ra	NP	INFunknownSUP
treatment	NN	treatment
.	SENT	.
debate.The	NN	INFunknownSUP
adenosine	NN	adenosine
A2A	NP	INFunknownSUP
receptor	NN	receptor
.	SENT	.
major	JJ	major
determinant	NN	determinant
of	IN	of
these	DT	these
organisms'	NP	INFunknownSUP
pathogenicity	NN	INFunknownSUP
.	SENT	.
anti-inflammatory	JJ	anti-inflammatory
cytokines	NNS	INFunknownSUP
.	SENT	.
viral	JJ	viral
infections	NNS	infection
of	IN	of
cardiotropic	JJ	INFunknownSUP
potential	NN	potential
.	SENT	.
use	NN	use
of	IN	of
HDCs	NP	INFunknownSUP
.	SENT	.
A.Non-homologous	JJ	INFunknownSUP
end-joining	NN	INFunknownSUP
.	SENT	.
study	NN	study
group	NN	group
.	SENT	.
metabolic-associated	JJ	INFunknownSUP
adipokine/cytokine	NN	INFunknownSUP
serum	NN	serum
assessment	NN	assessment
.	SENT	.
inhibition	NN	inhibition
of	IN	of
caspase-2	NN	INFunknownSUP
.	SENT	.
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
new	JJ	new
cells	NNS	cell
.	SENT	.
load	NN	load
power	NN	power
.	SENT	.
cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
amniotic	JJ	amniotic
membrane	NN	membrane
.	SENT	.
tissue	NN	tissue
oxygenation	NN	oxygenation
.	SENT	.
endothelium-dependent	JJ	INFunknownSUP
vasodilation	NN	INFunknownSUP
of	IN	of
the	DT	the
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
clinical	JJ	clinical
trials	NNS	trial
.	SENT	.
postoperative	JJ	postoperative
inflammatory	JJ	inflammatory
infiltration	NN	infiltration
.	SENT	.
CRPS	NP	INFunknownSUP
affected	JJ	affected
extremity	NN	extremity
.	SENT	.
light	NN	light
of	IN	of
the	DT	the
literature	NN	literature
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
NEOVASCULARIZATION	NP	INFunknownSUP
.	SENT	.
threshold	NN	threshold
load	NN	load
power	NN	power
.	SENT	.
cardiorenal	JJ	INFunknownSUP
syndrome	NN	syndrome
.	SENT	.
T.Cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
.	SENT	.
disease	NN	disease
progression	NN	progression
.	SENT	.
fusion	NN	fusion
protein	NN	protein
.	SENT	.
scald	NN	scald
burn	NN	burn
.	SENT	.
high-sensitivity	NN	INFunknownSUP
C-reactive	JJ	INFunknownSUP
.	SENT	.
defective	JJ	defective
migration	NN	migration
.	SENT	.
significant	JJ	significant
associations	NNS	association
.	SENT	.
early	JJ	early
stages	NNS	stage
.	SENT	.
protective	JJ	protective
role	NN	role
.	SENT	.
resolution	NN	resolution
of	IN	of
inflammation	NN	inflammation
.	SENT	.
potential	JJ	potential
pathogenetic	JJ	pathogenetic
factors	NNS	factor
.	SENT	.
cardiorenal	JJ	INFunknownSUP
medicine	NN	medicine
.	SENT	.
micronome	NN	INFunknownSUP
of	IN	of
FSK-MSCs	NP	INFunknownSUP
.	SENT	.
lectin	NP	INFunknownSUP
binding	JJ	binding
assay	NN	assay
.	SENT	.
clinical	JJ	clinical
scenarios	NNS	scenario
.	SENT	.
License	NP	License
4.0	NP	4.0
.	SENT	.
design.After	NP	INFunknownSUP
SCS	NP	INFunknownSUP
.	SENT	.
T.The	JJ	INFunknownSUP
fecal	JJ	fecal
microbiome	NN	INFunknownSUP
of	IN	of
ALS	JJ	INFunknownSUP
patients	NNS	patient
.	SENT	.
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
.	SENT	.
Hunner	NP	INFunknownSUP
type	NN	type
IC	NP	IC
.	SENT	.
Oral	JJ	oral
manifestation	NN	manifestation
of	IN	of
this	DT	this
disease	NN	disease
.	SENT	.
respiratory	JJ	respiratory
function	NN	function
.	SENT	.
D726A	NP	INFunknownSUP
mutation	NN	mutation
.	SENT	.
digestive	JJ	digestive
system	NN	system
.	SENT	.
joining-mediated	JJ	INFunknownSUP
DNA	NN	DNA
repair	NN	repair
.	SENT	.
repair	NN	repair
of	IN	of
DNA	NP	DNA
double-strand	NN	INFunknownSUP
breaks	NNS	break
.	SENT	.
Ku80/DNA-PKcs	NP	INFunknownSUP
interaction	NN	interaction
.	SENT	.
key	JJ	key
regulators	NNS	regulator
.	SENT	.
groups.Depressive	JJ	INFunknownSUP
symptoms	NNS	symptom
.	SENT	.
cross	NN	cross
talk	NN	talk
.	SENT	.
hormonal	JJ	hormonal
milieu	NN	milieu
.	SENT	.
disorder	NN	disorder
of	IN	of
the	DT	the
connective	JJ	connective
tissue	NN	tissue
.	SENT	.
progression	NN	progression
of	IN	of
chronic	JJ	chronic
kidney	NN	kidney
disease	NN	disease
.	SENT	.
normal	JJ	normal
leukocyte	NN	INFunknownSUP
.	SENT	.
formation	NN	formation
of	IN	of
a	DT	a
Ku70/Ku80/DNA-PKcs	NP	INFunknownSUP
complex	NN	complex
.	SENT	.
back	JJ	back
pain	NN	pain
patients	NNS	patient
.	SENT	.
wall	NN	wall
thickening	NN	thickening
.	SENT	.
functional	JJ	functional
properties	NNS	property
.	SENT	.
factor-	NN	INFunknownSUP
alpha	NN	alpha
.	SENT	.
chronic	JJ	chronic
back	JJ	back
pain	NN	pain
patients	NNS	patient
.	SENT	.
force	NN	force
of	IN	of
tendons	NNS	tendon
.	SENT	.
development	NN	development
of	IN	of
disease	NN	disease
.	SENT	.
immunomodulatory	JJ	INFunknownSUP
properties	NNS	property
.	SENT	.
T.[Dental	JJ	INFunknownSUP
perspective	NN	perspective
.	SENT	.
severity	NN	severity
of	IN	of
cardiovascular	JJ	cardiovascular
disease	NN	disease
.	SENT	.
cell	NN	cell
wall	NN	wall
.	SENT	.
influence	NN	influence
of	IN	of
inflammation	NN	inflammation
.	SENT	.
myocardial	JJ	myocardial
fibrosis	NN	fibrosis
.	SENT	.
anti-angiogenetic	JJ	INFunknownSUP
activity	NN	activity
.	SENT	.
secondary	JJ	secondary
disease	NN	disease
effects	NNS	effect
.	SENT	.
%	NN	%
of	IN	of
adult	JJ	adult
patients	NNS	patient
.	SENT	.
fatal	JJ	fatal
neurodegenerative	JJ	INFunknownSUP
motor	NN	motor
neuron	NN	neuron
disease	NN	disease
.	SENT	.
comparable	JJ	comparable
detail	NN	detail
.	SENT	.
different	JJ	different
taxonomic	JJ	taxonomic
levels	NNS	level
.	SENT	.
reservoir	NN	reservoir
of	IN	of
MSCs	NP	INFunknownSUP
.	SENT	.
selection	NN	selection
of	IN	of
patients	NNS	patient
.	SENT	.
effects	NNS	effect
of	IN	of
aging	NN	aging
.	SENT	.
A2AR-KO	NP	INFunknownSUP
mice	NNS	mouse
.	SENT	.
clinical	JJ	clinical
manifestation	NN	manifestation
.	SENT	.
burst	NN	burst
SCS	NP	INFunknownSUP
treatment	NN	treatment
.	SENT	.
body	NN	body
mass	NN	mass
index	NN	index
.	SENT	.
adaptive	JJ	adaptive
immunity	NN	immunity
.	SENT	.
pain-associated	JJ	INFunknownSUP
mood	NN	mood
.	SENT	.
current	JJ	current
knowledge	NN	knowledge
.	SENT	.
organ	NN	organ
complications	NNS	complication
.	SENT	.
etoposide	NP	etoposide
treatment	NN	treatment
.	SENT	.
higher	JJR	high
restenosis	NN	INFunknownSUP
rates.The	NN	INFunknownSUP
study	NN	study
population	NN	population
.	SENT	.
standard	JJ	standard
therapies	NNS	therapy
.	SENT	.
valuable	JJ	valuable
reservoir	NN	reservoir
of	IN	of
MSCs	NP	INFunknownSUP
.	SENT	.
severe	JJ	severe
burn	NN	burn
.	SENT	.
patients.The	NN	INFunknownSUP
presence	NN	presence
of	IN	of
depressive	JJ	depressive
symptoms	NNS	symptom
.	SENT	.
blood	NN	blood
parameters	NNS	parameter
.	SENT	.
quantification	NN	quantification
technique.Bladder	NN	INFunknownSUP
biopsy	NN	biopsy
specimens	NNS	specimen
.	SENT	.
percutaneous	JJ	percutaneous
coronary	JJ	coronary
intervention	NN	intervention
.	SENT	.
great	JJ	great
deal	NN	deal
of	IN	of
heterogeneity	NN	heterogeneity
.	SENT	.
virtual	JJ	virtual
histology-intravascular	JJ	INFunknownSUP
ultrasound	NN	ultrasound
.	SENT	.
kidney	NN	kidney
interactions	NNS	interaction
.	SENT	.
model	NN	model
of	IN	of
strabismus	NN	strabismus
surgery	NN	surgery
.	SENT	.
aim	NN	aim
of	IN	of
the	DT	the
article	NN	article
.	SENT	.
mast	NN	mast
cell	NN	cell
.	SENT	.
ALS	JJ	INFunknownSUP
pathogenesis	NN	pathogenesis
.	SENT	.
inflammatory	JJ	inflammatory
alternations	NNS	alternation
.	SENT	.
complicated	JJ	complicated
development	NN	development
of	IN	of
disease	NN	disease
.	SENT	.
restoration	NN	restoration
of	IN	of
the	DT	the
biota	NN	biota
of	IN	of
the	DT	the
human	JJ	human
body	NN	body
.	SENT	.
burn	NN	burn
site	NN	site
.	SENT	.
course	NN	course
of	IN	of
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
.	SENT	.
specialized	JJ	specialized
receptor	NN	receptor
.	SENT	.
necrosis	NN	necrosis
factor-	NN	INFunknownSUP
alpha	NN	alpha
.	SENT	.
9-month	NN	INFunknownSUP
follow-up	NN	follow-up
coronary	JJ	coronary
angiography	NN	angiography
.	SENT	.
Tryptophan	NN	tryptophan
levels	NNS	level
.	SENT	.
pioglitazone	NN	INFunknownSUP
intake	NN	intake
.	SENT	.
detrusor	NN	INFunknownSUP
areas	NNS	area
.	SENT	.
Cord	NP	Cord
Stimulation	NP	INFunknownSUP
.	SENT	.
parameters.Mast	NN	INFunknownSUP
cell	NN	cell
density	NN	density
.	SENT	.
clear	JJ	clear
need	NN	need
.	SENT	.
total	JJ	total
protein	NN	protein
.	SENT	.
age-related	JJ	age-related
conditions	NNS	condition
.	SENT	.
CLEC9A-Fc	NP	INFunknownSUP
fusion	NN	fusion
protein	NN	protein
.	SENT	.
PICRUSt-predicted	JJ	INFunknownSUP
metagenomes	NNS	INFunknownSUP
.	SENT	.
risk	NN	risk
of	IN	of
cancer	NN	cancer
.	SENT	.
improvement	NN	improvement
of	IN	of
respiratory	JJ	respiratory
function	NN	function
.	SENT	.
cardiovascular	JJ	cardiovascular
disease	NN	disease
.	SENT	.
group.Our	NN	INFunknownSUP
results	NNS	result
.	SENT	.
levels	NNS	level
of	IN	of
systolic	JJ	systolic
blood	NN	blood
pressure	NN	pressure
.	SENT	.
circulatory	JJ	circulatory
system	NN	system
.	SENT	.
deleterious	JJ	deleterious
effects	NNS	effect
.	SENT	.
baseline	JJ	baseline
coronary	JJ	coronary
plaque	NN	plaque
composition	NN	composition
.	SENT	.
adenosine	NN	adenosine
A2A	NP	INFunknownSUP
receptor	NN	receptor
.	SENT	.
inflammatory	JJ	inflammatory
marker	NN	marker
.	SENT	.
terminal	JJ	terminal
part	NN	part
of	IN	of
the	DT	the
small	JJ	small
intestine	NN	intestine
.	SENT	.
total	JJ	total
cholesterol	NN	cholesterol
.	SENT	.
development	NN	development
of	IN	of
therapeutic	JJ	therapeutic
approaches	NNS	approach
.	SENT	.
chronic	JJ	chronic
heart	NN	heart
failure	NN	failure
.	SENT	.
course	NN	course
of	IN	of
disorder	NN	disorder
.	SENT	.
inflammatory	JJ	inflammatory
diseases	NNS	disease
.	SENT	.
contralateral	JJ	INFunknownSUP
extremity	NN	extremity
.	SENT	.
case	NN	case
of	IN	of
choroidal	JJ	INFunknownSUP
inflammation.Case	NN	INFunknownSUP
report.A	NN	INFunknownSUP
41-year-old	JJ	41-year-old
man	NN	man
.	SENT	.
mass	NN	mass
index	NN	index
.	SENT	.
start	NN	start
of	IN	of
treatment	NN	treatment
.	SENT	.
mechanisms	NNS	mechanism
of	IN	of
heart	NN	heart
.	SENT	.
choroidal	JJ	INFunknownSUP
inflammation	NN	inflammation
.	SENT	.
ages.Several	JJ	INFunknownSUP
readouts	NNS	readout
.	SENT	.
presentation	NN	presentation
pathway	NN	pathway
.	SENT	.
terms	NNS	term
of	IN	of
diagnosis	NN	diagnosis
.	SENT	.
Oral	JJ	oral
lesions	NNS	lesion
.	SENT	.
A.Total	JJ	INFunknownSUP
leukocyte	NN	INFunknownSUP
count	NN	count
.	SENT	.
choroidal	JJ	INFunknownSUP
inflammation.Case	NN	INFunknownSUP
.	SENT	.
open-access	NN	open-access
article	NN	article
.	SENT	.
pain	NN	pain
intensity	NN	intensity
.	SENT	.
Mycobacterium	NN	mycobacterium
tuberculosis	NN	tuberculosis
.	SENT	.
lymphoplasmacytic	JJ	INFunknownSUP
cell	NN	cell
density	NN	density
.	SENT	.
development	NN	development
of	IN	of
depressive	JJ	depressive
symptoms	NNS	symptom
.	SENT	.
double-strand	NN	INFunknownSUP
breaks	NNS	break
.	SENT	.
serum	NN	serum
assessment	NN	assessment
.	SENT	.
immunotherapeutic	JJ	INFunknownSUP
cells	NNS	cell
.	SENT	.
non-white	JJ	non-white
patients	NNS	patient
.	SENT	.
T-cell	NN	T-cell
activation	NN	activation
.	SENT	.
cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
AM	NP	AM
.	SENT	.
tendon	NN	tendon
remodeling	NN	remodeling
.	SENT	.
angina	NN	angina
pectoris	NN	pectoris
FC	NP	FC
II	NP	II
.	SENT	.
left	JJ	left
eye	NN	eye
.	SENT	.
levels	NNS	level
of	IN	of
IP-10	NP	INFunknownSUP
.	SENT	.
measures	NNS	measure
design.After	NP	INFunknownSUP
SCS	NP	INFunknownSUP
.	SENT	.
remarkable	JJ	remarkable
interest	NN	interest
.	SENT	.
sensory	JJ	sensory
signs	NNS	sign
.	SENT	.
C-type	NP	INFunknownSUP
lectin	NN	INFunknownSUP
.	SENT	.
comprehensive	JJ	comprehensive
therapy	NN	therapy
.	SENT	.
terms	NNS	term
of	IN	of
the	DT	the
Creative	NP	Creative
Commons	NP	Commons
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
Derivatives	NP	INFunknownSUP
License	NP	License
4.0	NP	4.0
.	SENT	.
relative	JJ	relative
expression	NN	expression
of	IN	of
inflammatory	JJ	inflammatory
mediators	NNS	mediator
.	SENT	.
Recent	JJ	Recent
findings	NNS	finding
.	SENT	.
Tryptophan	NN	tryptophan
degradation	NN	degradation
.	SENT	.
atherosclerotic	JJ	atherosclerotic
process	NN	process
.	SENT	.
basic	JJ	basic
FGF	NN	INFunknownSUP
.	SENT	.
negative	JJ	negative
impact	NN	impact
.	SENT	.
Bladder	NN	bladder
biopsy	NN	biopsy
specimens	NNS	specimen
.	SENT	.
pharmaceutical	JJ	pharmaceutical
intervention	NN	intervention
.	SENT	.
T1-40	NP	INFunknownSUP
Hz	NP	hz
standard	JJ	standard
frequency	NN	frequency
stimulation	NN	stimulation
.	SENT	.
mast	NN	mast
cell	NN	cell
infiltration	NN	infiltration
.	SENT	.
M.	NP	M.
tuberculosis	NN	tuberculosis
H37Ra	NP	INFunknownSUP
.	SENT	.
A2A	NP	INFunknownSUP
receptor	NN	receptor
.	SENT	.
systemic	JJ	systemic
inflammation	NN	inflammation
hs-CRP	NP	INFunknownSUP
.	SENT	.
vitro	NP	Vitro
lectin	NP	INFunknownSUP
binding	JJ	binding
assay	NN	assay
.	SENT	.
protective	JJ	protective
impact	NN	impact
.	SENT	.
chronic	JJ	chronic
HF	NP	HF
patients	NNS	patient
.	SENT	.
T.Cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
amniotic	JJ	amniotic
membrane	NN	membrane
.	SENT	.
day	NN	day
of	IN	of
the	DT	the
study	NN	study
.	SENT	.
antiproliferative	JJ	INFunknownSUP
agent	NN	agent
vitamin	NN	vitamin
D	NP	D
.	SENT	.
damage	NN	damage
to	TO	to
multiple	JJ	multiple
organs	NNS	organ
.	SENT	.
intense	JJ	intense
research	NN	research
.	SENT	.
site	NN	site
of	IN	of
inflammation	NN	inflammation
.	SENT	.
caspase-2	JJ	INFunknownSUP
knockdown	NN	knockdown
.	SENT	.
pathogenetic	JJ	pathogenetic
factors	NNS	factor
.	SENT	.
Intake	NN	intake
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
wide	JJ	wide
variety	NN	variety
of	IN	of
biological	JJ	biological
processes	NNS	process
.	SENT	.
development	NN	development
conditions	NNS	condition
.	SENT	.
expression	NN	expression
of	IN	of
the	DT	the
inflammatory	JJ	inflammatory
marker	NN	marker
of	IN	of
hs-CRP	NP	INFunknownSUP
.	SENT	.
bilateral	JJ	bilateral
superior	JJ	superior
rectus	NN	rectus
.	SENT	.
arterial	JJ	arterial
pressure	NN	pressure
.	SENT	.
process	NN	process
of	IN	of
the	DT	the
gastrointestinal	JJ	gastrointestinal
tract	NN	tract
.	SENT	.
clinical	JJ	clinical
efficacy	NN	efficacy
.	SENT	.
therapeutic	JJ	therapeutic
capabilities	NNS	capability
.	SENT	.
diagnostic	JJ	diagnostic
methods	NNS	method
.	SENT	.
Ku80	NP	INFunknownSUP
interaction	NN	interaction
.	SENT	.
Multimodal	JJ	multimodal
imaging	NN	imaging
.	SENT	.
PTH	NP	INFunknownSUP
serum	NN	serum
concentration	NN	concentration
.	SENT	.
peripheral	JJ	peripheral
tissue	NN	tissue
oxygenation	NN	oxygenation
.	SENT	.
neurohormonal	JJ	INFunknownSUP
signals	NNS	signal
.	SENT	.
Pattern	NN	pattern
alteration	NN	alteration
.	SENT	.
collagen	NN	collagen
fibers	NNS	fiber
.	SENT	.
metabolic-associated	JJ	INFunknownSUP
adipokine/cytokine	NN	INFunknownSUP
.	SENT	.
higher	JJR	high
age	NN	age
.	SENT	.
neuroinflammation	NN	INFunknownSUP
assessment	NN	assessment
.	SENT	.
LP	NP	LP
levels	NNS	level
.	SENT	.
CD138-immunoreactive	JJ	INFunknownSUP
cells	NNS	cell
.	SENT	.
Cardiorenal	NP	INFunknownSUP
Medicine	NP	Medicine
.	SENT	.
core	NN	core
volume	NN	volume
.	SENT	.
presentation	NN	presentation
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
inflammatory	JJ	inflammatory
cytokines	NNS	INFunknownSUP
.	SENT	.
heart	NN	heart
failure	NN	failure
.	SENT	.
A.The	JJ	INFunknownSUP
mechanism	NN	mechanism
of	IN	of
in-stent	JJ	INFunknownSUP
restenosis	NN	INFunknownSUP
.	SENT	.
organisms'	NP	INFunknownSUP
pathogenicity	NN	INFunknownSUP
.	SENT	.
systemic	JJ	systemic
sclerosis	NN	sclerosis
.	SENT	.
medical	JJ	medical
center	NN	center
.	SENT	.
binding	JJ	binding
assay	NN	assay
.	SENT	.
fatal	JJ	fatal
syndromes	NNS	syndrome
.	SENT	.
control	NN	control
group	NN	group
.	SENT	.
biomechanical	JJ	biomechanical
changes	NNS	change
.	SENT	.
lack	NN	lack
of	IN	of
availability	NN	availability
to	TO	to
clinician	NN	clinician
scientists	NNS	scientist
of	IN	of
a	DT	a
helminth	NN	helminth
.	SENT	.
trophic	JJ	trophic
changes	NNS	change
.	SENT	.
internal	JJ	internal
organ	NN	organ
complications	NNS	complication
.	SENT	.
T.Severe	NP	INFunknownSUP
Burn-Induced	NP	INFunknownSUP
Inflammation	NP	INFunknownSUP
.	SENT	.
functional	JJ	functional
A2AR	NP	INFunknownSUP
.	SENT	.
percent	NN	percent
necrotic	JJ	necrotic
core	NN	core
volume	NN	volume
.	SENT	.
healthy	JJ	healthy
adults	NNS	adult
.	SENT	.
Metabolic	NP	INFunknownSUP
Disorders	NP	INFunknownSUP
Associated	NP	Associated
Peripheral	NP	INFunknownSUP
Cytokine/Adipokine	NP	INFunknownSUP
Traffic	NP	Traffic
.	SENT	.
T.Elevated	JJ	INFunknownSUP
leukocyte	NN	INFunknownSUP
count	NN	count
.	SENT	.
significant	JJ	significant
differences	NNS	difference
.	SENT	.
activation	NN	activation
of	IN	of
SYK	NP	INFunknownSUP
.	SENT	.
presence	NN	presence
of	IN	of
depressive	JJ	depressive
symptoms	NNS	symptom
.	SENT	.
adult	JJ	adult
patients	NNS	patient
.	SENT	.
respiratory	JJ	respiratory
rate	NN	rate
.	SENT	.
index	NN	index
of	IN	of
systemic	JJ	systemic
inflammation	NN	inflammation
hs-CRP	NP	INFunknownSUP
.	SENT	.
Mast	NN	mast
cell	NN	cell
.	SENT	.
choroidal	JJ	INFunknownSUP
neovascularization	NN	INFunknownSUP
involution	NN	involution
.	SENT	.
ISR.This	NP	INFunknownSUP
study	NN	study
.	SENT	.
Bone	NN	bone
mass	NN	mass
.	SENT	.
central	JJ	central
role	NN	role
.	SENT	.
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
transformation	NN	transformation
.	SENT	.
stress	NN	stress
level	NN	level
.	SENT	.
potential	JJ	potential
protective	JJ	protective
impact	NN	impact
.	SENT	.
new	JJ	new
definition	NN	definition
.	SENT	.
depressive	JJ	depressive
symptoms	NNS	symptom
.	SENT	.
model	NN	model
of	IN	of
tendinopathy	NN	INFunknownSUP
.	SENT	.
abundance	NN	abundance
of	IN	of
uncultured	JJ	INFunknownSUP
Ruminococcaceae	NP	INFunknownSUP
.	SENT	.
clinician	NN	clinician
scientists	NNS	scientist
of	IN	of
a	DT	a
helminth	NN	helminth
.	SENT	.
postoperative	JJ	postoperative
inflammation	NN	inflammation
.	SENT	.
clinical	JJ	clinical
manifestations	NNS	manifestation
.	SENT	.
old	JJ	old
age	NN	age
.	SENT	.
tumor	NN	tumor
necrosis	NN	necrosis
factor-	NN	INFunknownSUP
alpha	NN	alpha
.	SENT	.
socio-medical	JJ	INFunknownSUP
studies	NNS	study
.	SENT	.
leukocyte	NN	INFunknownSUP
counts	NNS	count
.	SENT	.
neutrophil	JJ	neutrophil
counts	NNS	count
.	SENT	.
changes	NNS	change
of	IN	of
GH	NP	GH
.	SENT	.
stronger	JJR	strong
prognostic	JJ	prognostic
ability	NN	ability
.	SENT	.
ongoing	JJ	ongoing
research	NN	research
.	SENT	.
altered	JJ	altered
composition	NN	composition
of	IN	of
the	DT	the
fecal	JJ	fecal
microbiota	NN	INFunknownSUP
.	SENT	.
blood	NN	blood
samples	NNS	sample
.	SENT	.
human	JJ	human
infectious	JJ	infectious
disease	NN	disease
.	SENT	.
fecal	JJ	fecal
microbiota	NN	INFunknownSUP
.	SENT	.
surface	NN	surface
cobblestoning	NN	INFunknownSUP
.	SENT	.
technical	JJ	technical
factors	NNS	factor
.	SENT	.
T2-preferred	JJ	INFunknownSUP
frequency	NN	frequency
stimulation	NN	stimulation
.	SENT	.
spinal	JJ	spinal
cord	NN	cord
stimulation	NN	stimulation
.	SENT	.
inflammatory	JJ	inflammatory
mediators	NNS	mediator
.	SENT	.
specific	JJ	specific
surface	NN	surface
glycans	NNS	INFunknownSUP
.	SENT	.
restenosis	NN	INFunknownSUP
rates.The	NN	INFunknownSUP
study	NN	study
population	NN	population
.	SENT	.
A.Systemic	JJ	INFunknownSUP
sclerosis	NN	sclerosis
.	SENT	.
significant	JJ	significant
decrease	NN	decrease
.	SENT	.
intracellular	JJ	intracellular
calcium	NN	calcium
overload	NN	overload
.	SENT	.
significance	NN	significance
of	IN	of
mast	NN	mast
cell	NN	cell
infiltration	NN	infiltration
.	SENT	.
postoperative	JJ	postoperative
adhesions	NNS	adhesion
.	SENT	.
agent	NN	agent
vitamin	NN	vitamin
D	NP	D
.	SENT	.
inflammatory	JJ	inflammatory
response	NN	response
.	SENT	.
Vascular	JJ	vascular
complications	NNS	complication
.	SENT	.
clinical	JJ	clinical
examinations	NNS	examination
.	SENT	.
significant	JJ	significant
changes	NNS	change
.	SENT	.
deal	NN	deal
of	IN	of
heterogeneity	NN	heterogeneity
.	SENT	.
vitamin	NN	vitamin
D	NP	D
.	SENT	.
smooth	JJ	smooth
muscle	NN	muscle
cells	NNS	cell
receptors	NNS	receptor
.	SENT	.
Western	JJ	Western
society	NN	society
.	SENT	.
expression	NN	expression
of	IN	of
anti-inflammatory	JJ	anti-inflammatory
cytokines	NNS	INFunknownSUP
.	SENT	.
22 ± 0.81	JJ	INFunknownSUP
kg/m(2	NN	INFunknownSUP
.	SENT	.
course	NN	course
of	IN	of
disease	NN	disease
.	SENT	.
protective	JJ	protective
effects	NNS	effect
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
rat	NN	rat
tapeworm	NN	tapeworm
.	SENT	.
presence	NN	presence
of	IN	of
choroidal	JJ	INFunknownSUP
neovascularization	NN	INFunknownSUP
.	SENT	.
degree	NN	degree
of	IN	of
background	NN	background
inflammation	NN	inflammation
.	SENT	.
endothelial	JJ	endothelial
dysfunction	NN	dysfunction
.	SENT	.
Common	JJ	common
clinical	JJ	clinical
scenarios	NNS	scenario
.	SENT	.
disease	NN	disease
effects	NNS	effect
.	SENT	.
collagens	NNS	collagen
I/III	NP	INFunknownSUP
.	SENT	.
aim	NN	aim
of	IN	of
the	DT	the
research	NN	research
.	SENT	.
clinical	JJ	clinical
presentation	NN	presentation
of	IN	of
the	DT	the
disease	NN	disease
.	SENT	.
chronotropic	JJ	INFunknownSUP
activation	NN	activation
.	SENT	.
products	NNS	product
kynurenine	NN	INFunknownSUP
.	SENT	.
A.Total	JJ	INFunknownSUP
leukocyte	NN	INFunknownSUP
.	SENT	.
full	JJ	full
list	NN	list
.	SENT	.
surface	NN	surface
of	IN	of
macrophages	NNS	macrophage
.	SENT	.
non-white	JJ	non-white
patients.The	NN	INFunknownSUP
presence	NN	presence
of	IN	of
depressive	JJ	depressive
symptoms	NNS	symptom
.	SENT	.
right	JJ	right
eye	NN	eye
.	SENT	.
in-stent	JJ	INFunknownSUP
restenosis	NN	INFunknownSUP
.	SENT	.
chronic	JJ	chronic
kidney	NN	kidney
disease	NN	disease
.	SENT	.
therapeutic	JJ	therapeutic
possibilities	NNS	possibility
.	SENT	.
skin	NN	skin
blisters	NNS	blister
.	SENT	.
relevant	JJ	relevant
functional	JJ	functional
properties	NNS	property
.	SENT	.
control	NN	control
specimens	NNS	specimen
.	SENT	.
immunological	JJ	immunological
profile	NN	profile
.	SENT	.
innate	JJ	innate
immune	JJ	immune
response	NN	response
.	SENT	.
flow	NN	flow
velocity	NN	velocity
.	SENT	.
endothelium	NN	endothelium
protective	JJ	protective
effect	NN	effect
of	IN	of
long-term	JJ	long-term
pioglitazone	NN	INFunknownSUP
intake	NN	intake
.	SENT	.
endothelium-dependent	JJ	INFunknownSUP
vasodilation	NN	INFunknownSUP
of	IN	of
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
enrichment	NN	enrichment
analysis	NN	analysis
.	SENT	.
inclusion	NN	inclusion
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
CRPS	NP	INFunknownSUP
studies	NNS	study
.	SENT	.
cell	NN	cell
infiltration	NN	infiltration
.	SENT	.
SCS	NP	INFunknownSUP
therapy	NN	therapy
.	SENT	.
Inflammatory	JJ	inflammatory
involvement	NN	involvement
.	SENT	.
body	NN	body
surface	NN	surface
area	NN	area
scald	NN	scald
burn	NN	burn
.	SENT	.
specific	JJ	specific
immune	JJ	immune
response	NN	response
.	SENT	.
inflammatory	JJ	inflammatory
reaction	NN	reaction
.	SENT	.
further	JJR	further
classification	NN	classification
criteria	NNS	criterion
.	SENT	.
male	JJ	male
Sprague-Dawley	NP	INFunknownSUP
rats	NNS	rat
.	SENT	.
relevant	JJ	relevant
issue	NN	issue
of	IN	of
modern	JJ	modern
therapy	NN	therapy
.	SENT	.
smooth	JJ	smooth
muscle	NN	muscle
cells	NNS	cell
.	SENT	.
biopsy	NN	biopsy
specimens	NNS	specimen
.	SENT	.
significant	JJ	significant
increase	NN	increase
.	SENT	.
T.Elevated	JJ	INFunknownSUP
leukocyte	NN	INFunknownSUP
.	SENT	.
neurodegenerative	JJ	INFunknownSUP
motor	NN	motor
neuron	NN	neuron
disease	NN	disease
.	SENT	.
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
.	SENT	.
nonconforming	JJ	INFunknownSUP
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
.	SENT	.
choroidal	JJ	INFunknownSUP
inflammation.Case	NN	INFunknownSUP
report.A	NN	INFunknownSUP
41-year-old	JJ	41-year-old
man	NN	man
.	SENT	.
A.Mesenchymal	JJ	INFunknownSUP
stromal	JJ	INFunknownSUP
cells	NNS	cell
.	SENT	.
complexity	NN	complexity
of	IN	of
SSc	NP	INFunknownSUP
.	SENT	.
number	NN	number
of	IN	of
years	NNS	year
.	SENT	.
Gene	NN	gene
expression	NN	expression
.	SENT	.
profile	NN	profile
of	IN	of
the	DT	the
relative	JJ	relative
expression	NN	expression
of	IN	of
inflammatory	JJ	inflammatory
mediators	NNS	mediator
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
NEOVASCULARIZATION	NP	INFunknownSUP
ASSOCIATED	NP	Associated
WITH	NP	INFunknownSUP
FOCAL	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
EXCAVATION	NP	INFunknownSUP
.	SENT	.
infectious	JJ	infectious
disease	NN	disease
.	SENT	.
surface	NN	surface
area	NN	area
scald	NN	scald
burn	NN	burn
.	SENT	.
idiophatic	JJ	INFunknownSUP
inflammatory	JJ	inflammatory
process	NN	process
of	IN	of
the	DT	the
gastrointestinal	JJ	gastrointestinal
tract	NN	tract
.	SENT	.
determinant	NN	determinant
of	IN	of
these	DT	these
organisms'	NP	INFunknownSUP
pathogenicity	NN	INFunknownSUP
.	SENT	.
standard	JJ	standard
frequency	NN	frequency
stimulation	NN	stimulation
.	SENT	.
degradation	NN	degradation
products	NNS	product
kynurenine	NN	INFunknownSUP
.	SENT	.
DNA	NP	DNA
double-strand	NN	INFunknownSUP
breaks	NNS	break
.	SENT	.
coherence	NN	coherence
tomography	NN	tomography
angiography	NN	angiography
.	SENT	.
anti-inflammatory	JJ	anti-inflammatory
IL-10	NP	INFunknownSUP
serum	NN	serum
levels	NNS	level
.	SENT	.
meaningful	JJ	meaningful
differences	NNS	difference
.	SENT	.
impact	NN	impact
of	IN	of
long-term	JJ	long-term
intake	NN	intake
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
oxidative	JJ	oxidative
stress	NN	stress
.	SENT	.
cocktail	NN	cocktail
of	IN	of
proinflammatory	JJ	INFunknownSUP
cytokines	NNS	INFunknownSUP
.	SENT	.
Achilles	NP	Achilles
tendons	NNS	tendon
.	SENT	.
T.Spinal	NP	INFunknownSUP
Cord	NP	Cord
Stimulation	NP	INFunknownSUP
.	SENT	.
choroidal	JJ	INFunknownSUP
neovascularization	NN	INFunknownSUP
.	SENT	.
mode	NN	mode
of	IN	of
action	NN	action
.	SENT	.
choroidal	JJ	INFunknownSUP
neovascularization	NN	INFunknownSUP
reduction	NN	reduction
.	SENT	.
A.Complex	NP	INFunknownSUP
regional	JJ	regional
pain	NN	pain
syndrome	NN	syndrome
.	SENT	.
pectoris	NN	pectoris
FC	NP	FC
II	NP	II
.	SENT	.
baseline.This	NN	INFunknownSUP
study	NN	study
.	SENT	.
prognostic	JJ	prognostic
ability	NN	ability
.	SENT	.
psychological	JJ	psychological
stress	NN	stress
.	SENT	.
certain	JJ	certain
groups	NNS	group
of	IN	of
population	NN	population
.	SENT	.
oral	JJ	oral
steroids	NNS	steroid
.	SENT	.
rate	NN	rate
of	IN	of
threshold	NN	threshold
load	NN	load
power	NN	power
.	SENT	.
Sprague-Dawley	NP	INFunknownSUP
rats	NNS	rat
.	SENT	.
background	NN	background
inflammation	NN	inflammation
.	SENT	.
particular	JJ	particular
C-type	NP	INFunknownSUP
lectin	NN	INFunknownSUP
receptors	NNS	receptor
.	SENT	.
natriuretic	NN	INFunknownSUP
peptides	NNS	peptide
.	SENT	.
cardiovascular	JJ	cardiovascular
diseases.At	NN	INFunknownSUP
baseline	NN	baseline
.	SENT	.
air	NN	air
pouches	NNS	pouch
.	SENT	.
potential	JJ	potential
use	NN	use
.	SENT	.
Ku80	NP	INFunknownSUP
cleavage	NN	cleavage
.	SENT	.
Rat	NP	INFunknownSUP
Model	NP	Model
.	SENT	.
poor	JJ	poor
prognosis	NN	prognosis
.	SENT	.
surface	NN	surface
glycans	NNS	INFunknownSUP
.	SENT	.
microbiome	NN	INFunknownSUP
alterations	NNS	alteration
.	SENT	.
non-specific	JJ	INFunknownSUP
chronic	JJ	chronic
cystitis	NN	cystitis
.	SENT	.
sensory	JJ	sensory
abnormalities	NNS	abnormality
.	SENT	.
environmental	JJ	environmental
factors	NNS	factor
.	SENT	.
Histological	JJ	histological
analysis	NN	analysis
.	SENT	.
quantitative	JJ	quantitative
analysis	NN	analysis
.	SENT	.
damage	NN	damage
inflammation	NN	inflammation
.	SENT	.
kidney	NN	kidney
disease	NN	disease
.	SENT	.
cryopreserved	JJ	INFunknownSUP
AM	NP	AM
allograft	NN	INFunknownSUP
.	SENT	.
lung	NN	lung
inflammation	NN	inflammation
.	SENT	.
helminthic	JJ	helminthic
therapy	NN	therapy
.	SENT	.
course	NN	course
of	IN	of
standard	JJ	standard
therapy	NN	therapy
.	SENT	.
cytokine	NN	INFunknownSUP
accumulation	NN	accumulation
.	SENT	.
stromal	JJ	INFunknownSUP
cells	NNS	cell
.	SENT	.
new	JJ	new
therapeutic	JJ	therapeutic
possibilities	NNS	possibility
.	SENT	.
expression	NN	expression
of	IN	of
IL-6	NP	INFunknownSUP
.	SENT	.
frequency	NN	frequency
stimulation	NN	stimulation
.	SENT	.
Metabolic	NP	INFunknownSUP
Disorders	NP	INFunknownSUP
Associated	NP	Associated
Peripheral	NP	INFunknownSUP
Cytokine/Adipokine	NP	INFunknownSUP
.	SENT	.
overall	JJ	overall
number	NN	number
of	IN	of
microbial	JJ	microbial
species	NNS	specie
.	SENT	.
dialysis	NN	dialysis
patients	NNS	patient
.	SENT	.
motor	NN	motor
neuron	NN	neuron
disease	NN	disease
.	SENT	.
optical	JJ	optical
coherence	NN	coherence
tomography	NN	tomography
angiography	NN	angiography
.	SENT	.
metabolic-associated	JJ	INFunknownSUP
cytokines/adipokines	NNS	INFunknownSUP
.	SENT	.
fate	NN	fate
of	IN	of
FSK-MSCs	NP	INFunknownSUP
.	SENT	.
BA	NP	BA
concurrent	NN	concurrent
.	SENT	.
bacterial	JJ	bacterial
taxa	NNS	taxon
.	SENT	.
pathophysiological	JJ	INFunknownSUP
pathways	NNS	pathway
.	SENT	.
low-density	NN	low-density
lipoproteins	NNS	lipoprotein
.	SENT	.
target	NN	target
pathways	NNS	pathway
.	SENT	.
T.[Modern	JJ	INFunknownSUP
perspective	NN	perspective
.	SENT	.
kynurenine	JJ	INFunknownSUP
pathway	NN	pathway
.	SENT	.
CRPS	NP	INFunknownSUP
signs	NNS	sign
.	SENT	.
CHD.The	JJ	INFunknownSUP
clinical	JJ	clinical
study	NN	study
.	SENT	.
long-term	JJ	long-term
intake	NN	intake
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
analysis	NN	analysis
software	NN	software
.	SENT	.
artificial	JJ	artificial
skin	NN	skin
blisters	NNS	blister
.	SENT	.
normal	JJ	normal
bladder	NN	bladder
.	SENT	.
real-time	JJ	real-time
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
.	SENT	.
important	JJ	important
atherosclerotic	JJ	atherosclerotic
process	NN	process
.	SENT	.
GH	NP	GH
serum	NN	serum
levels	NNS	level
.	SENT	.
Mast	NN	Mast
cell	NN	cell
tryptase-	NN	INFunknownSUP
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
NEOVASCULARIZATION	NP	INFunknownSUP
ASSOCIATED	NP	Associated
WITH	NP	INFunknownSUP
.	SENT	.
regional	JJ	regional
pain	NN	pain
syndrome	NN	syndrome
.	SENT	.
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
Derivatives	NP	INFunknownSUP
.	SENT	.
immune	JJ	immune
system	NN	system
.	SENT	.
connective	JJ	connective
tissue	NN	tissue
.	SENT	.
cardiac	JJ	cardiac
events	NNS	event
.	SENT	.
inflammatory	JJ	inflammatory
cytokines	NNS	INFunknownSUP
activity	NN	activity
.	SENT	.
effects	NNS	effect
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
non-white	JJ	non-white
dialysis	NN	dialysis
patients	NNS	patient
.	SENT	.
IC	NP	IC
specimens	NNS	specimen
.	SENT	.
Caspase-2-mediated	NP	INFunknownSUP
Ku80	NP	INFunknownSUP
cleavage	NN	cleavage
.	SENT	.
Ku80	NP	INFunknownSUP
ΔC6	NN	INFunknownSUP
.	SENT	.
immune	JJ	immune
system	NN	system
activation	NN	activation
.	SENT	.
end	NN	end
joining-mediated	JJ	INFunknownSUP
DNA	NN	DNA
repair	NN	repair
.	SENT	.
future	JJ	future
clinical	JJ	clinical
trials	NNS	trial
.	SENT	.
certain	JJ	certain
diseases	NNS	disease
.	SENT	.
multiple	JJ	multiple
organs	NNS	organ
.	SENT	.
diminished	JJ	diminished
endothelial	JJ	endothelial
dysfunction	NN	dysfunction
.	SENT	.
serum	NN	serum
changes	NNS	change
of	IN	of
metabolic-associated	JJ	INFunknownSUP
cytokines/adipokines	NNS	INFunknownSUP
.	SENT	.
further	JJR	further
research	NN	research
.	SENT	.
important	JJ	important
factor	NN	factor
.	SENT	.
cytokine	JJ	INFunknownSUP
analysis	NN	analysis
.	SENT	.
Sham-treated	JJ	INFunknownSUP
animals	NNS	animal
.	SENT	.
tobacco-induced	JJ	INFunknownSUP
inflammatory	JJ	inflammatory
changes	NNS	change
.	SENT	.
health	NN	health
outcomes	NNS	outcome
.	SENT	.
clinical	JJ	clinical
study	NN	study
.	SENT	.
expression	NN	expression
of	IN	of
inflammatory	JJ	inflammatory
cytokines	NNS	INFunknownSUP
.	SENT	.
induction	NN	induction
of	IN	of
inflammation	NN	inflammation
.	SENT	.
prognostic	JJ	prognostic
markers	NNS	marker
.	SENT	.
Ku80	NP	INFunknownSUP
ΔC6	NN	INFunknownSUP
overexpression	NN	INFunknownSUP
.	SENT	.
NHEJ)-mediated	JJ	INFunknownSUP
repair	NN	repair
of	IN	of
DNA	NP	DNA
double-strand	NN	INFunknownSUP
breaks	NNS	break
.	SENT	.
setting	NN	setting
of	IN	of
CRS	NP	CRS
.	SENT	.
kidney	NN	kidney
injury	NN	injury
.	SENT	.
efficient	JJ	efficient
scheme	NN	scheme
.	SENT	.
autoimmune/	JJ	INFunknownSUP
inflammatory	JJ	inflammatory
alternations	NNS	alternation
.	SENT	.
diagnosis	NN	diagnosis
of	IN	of
systemic	JJ	systemic
sclerosis	NN	sclerosis
.	SENT	.
coronary	JJ	coronary
plaque	NN	plaque
composition	NN	composition
.	SENT	.
affected	JJ	affected
extremity	NN	extremity
.	SENT	.
frequency	NN	frequency
of	IN	of
angina	NN	angina
pectoris	NN	pectoris
FC	NP	FC
II	NP	II
.	SENT	.
activity	NN	activity
assessment	NN	assessment
.	SENT	.
protective	JJ	protective
effect	NN	effect
of	IN	of
long-term	JJ	long-term
pioglitazone	NN	INFunknownSUP
intake	NN	intake
.	SENT	.
endothelium-dependent	JJ	INFunknownSUP
vasodilation	NN	INFunknownSUP
.	SENT	.
coronary	JJ	coronary
heart	NN	heart
.	SENT	.
disease	NN	disease
development	NN	development
.	SENT	.
area	NN	area
of	IN	of
intense	JJ	intense
research	NN	research
.	SENT	.
uncultured	JJ	INFunknownSUP
Ruminococcaceae	NP	INFunknownSUP
.	SENT	.
tomography	NN	tomography
angiography	NN	angiography
.	SENT	.
medical	JJ	medical
check-ups	NNS	check-up
.	SENT	.
Metabolic	NP	INFunknownSUP
Disorders	NP	INFunknownSUP
.	SENT	.
novel	JJ	novel
CLR	NP	INFunknownSUP
.	SENT	.
oral	JJ	oral
steroids.Multimodal	JJ	INFunknownSUP
imaging	NN	imaging
.	SENT	.
metabolic	JJ	metabolic
disorders	NNS	disorder
.	SENT	.
reliable	JJ	reliable
inflammatory	JJ	inflammatory
markers	NNS	marker
.	SENT	.
chain	NN	chain
reaction	NN	reaction
.	SENT	.
consequences	NNS	consequence
of	IN	of
biota	NN	biota
depletion	NN	depletion
.	SENT	.
certain	JJ	certain
prognostic	JJ	prognostic
markers	NNS	marker
.	SENT	.
human	JJ	human
body	NN	body
.	SENT	.
calcium	NN	calcium
overload	NN	overload
.	SENT	.
T.The	JJ	INFunknownSUP
fecal	JJ	fecal
microbiome	NN	INFunknownSUP
.	SENT	.
organized	JJ	organized
collagen	NN	collagen
fibers	NNS	fiber
.	SENT	.
A.Vitamin	NP	INFunknownSUP
D	NP	D
.	SENT	.
inflammatory	JJ	inflammatory
marker	NN	marker
of	IN	of
hs-CRP	NP	INFunknownSUP
.	SENT	.
heart-kidney	NN	INFunknownSUP
cross	NN	cross
talk	NN	talk
.	SENT	.
Metabolic	NP	INFunknownSUP
Disorders	NP	INFunknownSUP
Associated	NP	Associated
Peripheral	NP	INFunknownSUP
.	SENT	.
A.Treatment	NN	INFunknownSUP
of	IN	of
co-morbidities	NNS	INFunknownSUP
.	SENT	.
primary	JJ	primary
outcome	NN	outcome
parameters	NNS	parameter
.	SENT	.
energy	NN	energy
metabolism	NN	metabolism
.	SENT	.
non-specific	JJ	INFunknownSUP
clinical	JJ	clinical
manifestation	NN	manifestation
.	SENT	.
interaction	NN	interaction
of	IN	of
M.	NP	M.
tuberculosis	NN	tuberculosis
.	SENT	.
mycobacterial	JJ	INFunknownSUP
infection	NN	infection
.	SENT	.
nervous	JJ	nervous
system-specific	NN	system-specific
inflammation	NN	inflammation
.	SENT	.
individual	JJ	individual
variability	NN	variability
.	SENT	.
burn	NN	burn
rats.We	NNS	INFunknownSUP
.	SENT	.
potential	JJ	potential
therapy	NN	therapy
targets	NNS	target
.	SENT	.
diseases.At	NN	INFunknownSUP
baseline	NN	baseline
.	SENT	.
innate	JJ	innate
immunity	NN	immunity
.	SENT	.
mouse	NN	mouse
model	NN	model
.	SENT	.
mechanisms	NNS	mechanism
of	IN	of
action	NN	action
.	SENT	.
normal	JJ	normal
leukocyte	NN	INFunknownSUP
counts	NNS	count
.	SENT	.
chronic	JJ	chronic
dialysis	NN	dialysis
patients	NNS	patient
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
NEOVASCULARIZATION	NP	INFunknownSUP
ASSOCIATED	NP	Associated
WITH	NP	INFunknownSUP
FOCAL	NP	INFunknownSUP
.	SENT	.
lamina	NN	lamina
propria	NN	INFunknownSUP
.	SENT	.
41-year-old	JJ	41-year-old
man	NN	man
.	SENT	.
attention	NN	attention
to	TO	to
hemodynamics	NNS	INFunknownSUP
.	SENT	.
number	NN	number
of	IN	of
microbial	JJ	microbial
species	NNS	specie
.	SENT	.
CRPS	NP	INFunknownSUP
patients.The	JJ	INFunknownSUP
primary	JJ	primary
outcome	NN	outcome
parameters	NNS	parameter
.	SENT	.
bronchial	JJ	bronchial
asthma	NN	asthma
concurrent	NN	concurrent
.	SENT	.
immunological	JJ	immunological
fate	NN	fate
of	IN	of
FSK-MSCs	NP	INFunknownSUP
.	SENT	.
aim	NN	aim
of	IN	of
this	DT	this
study	NN	study
.	SENT	.
interstitial	JJ	interstitial
fluid	NN	fluid
of	IN	of
artificial	JJ	artificial
skin	NN	skin
blisters	NNS	blister
.	SENT	.
vasomotor	JJ	vasomotor
disturbances	NNS	disturbance
.	SENT	.
genomic	JJ	INFunknownSUP
stability	NN	stability
maintenance	NN	maintenance
.	SENT	.
air	NN	air
pouch	NN	pouch
.	SENT	.
composition	NN	composition
of	IN	of
the	DT	the
fecal	JJ	fecal
microbiota	NN	INFunknownSUP
.	SENT	.
novel	JJ	novel
mechanism	NN	mechanism
.	SENT	.
central	JJ	central
nervous	JJ	nervous
system-specific	NN	system-specific
inflammation	NN	inflammation
.	SENT	.
parameters.Mast	NN	INFunknownSUP
cell	NN	cell
.	SENT	.
inflammatory	JJ	inflammatory
infiltration	NN	infiltration
.	SENT	.
non-homologous	JJ	INFunknownSUP
end	NN	end
joining-mediated	JJ	INFunknownSUP
DNA	NN	DNA
repair	NN	repair
.	SENT	.
continued	JJ	continued
pain	NN	pain
.	SENT	.
T.Changes	NNS	INFunknownSUP
of	IN	of
Metabolic	NP	INFunknownSUP
Disorders	NP	INFunknownSUP
Associated	NP	Associated
Peripheral	NP	INFunknownSUP
Cytokine/Adipokine	NP	INFunknownSUP
Traffic	NP	Traffic
.	SENT	.
outcome	NN	outcome
parameters	NNS	parameter
.	SENT	.
core	JJ	core
curriculum	NN	curriculum
.	SENT	.
elevated	JJ	elevated
leukocyte	NN	INFunknownSUP
count	NN	count
.	SENT	.
confidence	NN	confidence
interval	NN	interval
.	SENT	.
gut	NN	gut
microbiota	NN	INFunknownSUP
composition	NN	composition
.	SENT	.
older	JJR	old
adults	NNS	adult
.	SENT	.
acute	JJ	acute
heart	NN	heart
failure	NN	failure
.	SENT	.
result	NN	result
of	IN	of
a	DT	a
combination	NN	combination
of	IN	of
vascular	JJ	vascular
damage	NN	damage
inflammation	NN	inflammation
.	SENT	.
Caspase-2-mediated	NP	INFunknownSUP
Ku80	NP	INFunknownSUP
.	SENT	.
%	NN	%
diameter	NN	diameter
of	IN	of
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
vitamin	NN	vitamin
D	NP	D
serum	NN	serum
concentration	NN	concentration
.	SENT	.
classification	NN	classification
criteria	NNS	criterion
.	SENT	.
proper	JJ	proper
diagnosis	NN	diagnosis
.	SENT	.
physicians	NNS	physician
of	IN	of
the	DT	the
future	NN	future
.	SENT	.
16S	JJ	INFunknownSUP
rRNA	NN	INFunknownSUP
.	SENT	.
numerous	JJ	numerous
studies	NNS	study
.	SENT	.
border	NN	border
of	IN	of
the	DT	the
excavation	NN	excavation
.	SENT	.
bronchial	JJ	bronchial
asthma	NN	asthma
.	SENT	.
digital	JJ	digital
quantification	NN	quantification
technique.Bladder	NN	INFunknownSUP
biopsy	NN	biopsy
specimens	NNS	specimen
.	SENT	.
antigen	NN	antigen
processing	NN	processing
.	SENT	.
developed	JJ	developed
countries	NNS	country
.	SENT	.
limited	JJ	limited
SSc	NP	INFunknownSUP
.	SENT	.
Commons	NP	Commons
Attribution-Non	NP	INFunknownSUP
Commercial-No	NP	INFunknownSUP
Derivatives	NP	INFunknownSUP
License	NP	License
4.0	NP	4.0
.	SENT	.
negative	JJ	negative
influence	NN	influence
.	SENT	.
CRPS	NP	INFunknownSUP
patients	NNS	patient
.	SENT	.
mechanism	NN	mechanism
of	IN	of
in-stent	JJ	INFunknownSUP
restenosis	NN	INFunknownSUP
.	SENT	.
development	NN	development
of	IN	of
inflammation	NN	inflammation
.	SENT	.
protein	NN	protein
ratio	NN	ratio
.	SENT	.
Inclusion	NN	inclusion
of	IN	of
pioglitazone	NN	INFunknownSUP
.	SENT	.
patients	NNS	patient
of	IN	of
the	DT	the
study	NN	study
group	NN	group
.	SENT	.
proinflammatory	JJ	INFunknownSUP
cytokines	NNS	INFunknownSUP
.	SENT	.
non-inflamed	JJ	INFunknownSUP
bladder	NN	bladder
.	SENT	.
atherosclerosis	NN	atherosclerosis
progression	NN	progression
.	SENT	.
maximum	JJ	maximum
blood	NN	blood
flow	NN	flow
velocity	NN	velocity
.	SENT	.
age-/gender-matched	JJ	INFunknownSUP
healthy	JJ	healthy
controls	NNS	control
.	SENT	.
Biomechanical	JJ	biomechanical
analysis	NN	analysis
.	SENT	.
Collagens	NP	INFunknownSUP
I	NP	I
.	SENT	.
taxonomic	JJ	taxonomic
levels	NNS	level
.	SENT	.
restenosis	NN	INFunknownSUP
rates.The	NN	INFunknownSUP
study	NN	study
.	SENT	.
medical	JJ	medical
schools	NNS	school
.	SENT	.
pattern	NN	pattern
recognition	NN	recognition
receptors	NNS	receptor
.	SENT	.
neutrophil	JJ	neutrophil
functions	NNS	function
.	SENT	.
digital	JJ	digital
image	NN	image
analysis	NN	analysis
software	NN	software
.	SENT	.
protective	JJ	protective
effect	NN	effect
.	SENT	.
reliable	JJ	reliable
morphological	JJ	morphological
indicators	NNS	indicator
of	IN	of
chronic	JJ	chronic
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
DNA	NN	DNA
repair	NN	repair
.	SENT	.
FC	NP	FC
I	NP	I
.	SENT	.
all-cause	JJ	INFunknownSUP
mortality	NN	mortality
.	SENT	.
muscle	NN	muscle
resection	NN	resection
.	SENT	.
restenosis	NN	INFunknownSUP
rates.The	NN	INFunknownSUP
.	SENT	.
Tiffeneau	NP	INFunknownSUP
index	NN	index
.	SENT	.
Δ	JJ	INFunknownSUP
%	NN	%
diameter	NN	diameter
increase	NN	increase
.	SENT	.
inflammatory	JJ	inflammatory
markers	NNS	marker
.	SENT	.
diameter	NN	diameter
of	IN	of
brachial	JJ	brachial
artery	NN	artery
.	SENT	.
white	JJ	white
rabbits	NNS	rabbit
.	SENT	.
post-SCS	NP	INFunknownSUP
LP	NP	LP
levels	NNS	level
.	SENT	.
serum	NN	serum
levels	NNS	level
.	SENT	.
system-specific	NN	system-specific
inflammation	NN	inflammation
.	SENT	.
treatment	NN	treatment
of	IN	of
these	DT	these
diseases	NNS	disease
.	SENT	.
p	NN	p
&lt	NN	INFunknownSUP
.	SENT	.
systemic	JJ	systemic
conditions	NNS	condition
.	SENT	.
VH-IVUS	NP	INFunknownSUP
examination	NN	examination
.	SENT	.
technique.Bladder	NN	INFunknownSUP
biopsy	NN	biopsy
specimens	NNS	specimen
.	SENT	.
surgical	JJ	surgical
specialists	NNS	specialist
.	SENT	.
part	NN	part
of	IN	of
the	DT	the
digestive	JJ	digestive
system	NN	system
.	SENT	.
resected	JJ	INFunknownSUP
SR	NN	SR
muscle	NN	muscle
.	SENT	.
microbial	JJ	microbial
species	NNS	specie
.	SENT	.
inflammatory	JJ	inflammatory
process	NN	process
of	IN	of
the	DT	the
gastrointestinal	JJ	gastrointestinal
tract	NN	tract
.	SENT	.
tryptophan	NN	tryptophan
degradation	NN	degradation
.	SENT	.
clinical	JJ	clinical
parameters.Mast	NN	INFunknownSUP
cell	NN	cell
density	NN	density
.	SENT	.
International	NP	International
Society	NP	Society
.	SENT	.
morphological	JJ	morphological
indicators	NNS	indicator
of	IN	of
chronic	JJ	chronic
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
cytokines	NNS	INFunknownSUP
activity	NN	activity
.	SENT	.
Secondary	JJ	secondary
outcome	NN	outcome
parameters	NNS	parameter
.	SENT	.
DSB	NP	INFunknownSUP
sites	NNS	site
.	SENT	.
classification	NN	classification
of	IN	of
cardiorenal	JJ	INFunknownSUP
syndrome	NN	syndrome
.	SENT	.
ultimate	JJ	ultimate
force	NN	force
of	IN	of
tendons	NNS	tendon
.	SENT	.
chronic	JJ	chronic
psychological	JJ	psychological
stress	NN	stress
.	SENT	.
indicators	NNS	indicator
of	IN	of
chronic	JJ	chronic
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
compliant	JJ	compliant
criteria	NNS	criterion
.	SENT	.
follow-up	NN	follow-up
coronary	JJ	coronary
angiography	NN	angiography
.	SENT	.
abundance	NN	abundance
of	IN	of
the	DT	the
bacterial	JJ	bacterial
taxa	NNS	taxon
.	SENT	.
cytokine	NN	INFunknownSUP
pattern	NN	pattern
.	SENT	.
angina	NN	angina
FC	NP	FC
I	NP	I
.	SENT	.
similar	JJ	similar
degree	NN	degree
of	IN	of
background	NN	background
inflammation	NN	inflammation
.	SENT	.
recognition	NN	recognition
receptors	NNS	receptor
.	SENT	.
%	NN	%
CI	NP	INFunknownSUP
.	SENT	.
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
neutrophil-related	JJ	INFunknownSUP
activities	NNS	activity
.	SENT	.
high-sensitivity	NN	INFunknownSUP
C-reactive	JJ	INFunknownSUP
protein	NN	protein
.	SENT	.
effects	NNS	effect
of	IN	of
SCS	NP	INFunknownSUP
.	SENT	.
taxonomic	JJ	taxonomic
units	NNS	unit
.	SENT	.
adhesion	NN	adhesion
marker	NN	marker
sVCAM-1	NN	INFunknownSUP
.	SENT	.
post-SCS	NN	INFunknownSUP
changes	NNS	change
of	IN	of
GH	NP	GH
.	SENT	.
serum	NN	serum
concentration	NN	concentration
.	SENT	.
chronic	JJ	chronic
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
long-term	JJ	long-term
survival	NN	survival
.	SENT	.
pain	NN	pain
patients	NNS	patient
.	SENT	.
changes	NNS	change
of	IN	of
metabolic-associated	JJ	INFunknownSUP
cytokines/adipokines	NNS	INFunknownSUP
.	SENT	.
A.Helminthic	JJ	INFunknownSUP
therapy	NN	therapy
.	SENT	.
cryopreserved	JJ	INFunknownSUP
rabbit	NNS	rabbit
.	SENT	.
disease	NN	disease
course	NN	course
.	SENT	.
population-wide	JJ	INFunknownSUP
restoration	NN	restoration
of	IN	of
the	DT	the
biota	NN	biota
of	IN	of
the	DT	the
human	JJ	human
body	NN	body
.	SENT	.
harbinger	NN	harbinger
of	IN	of
systemic	JJ	systemic
inflammation	NN	inflammation
.	SENT	.
availability	NN	availability
to	TO	to
clinician	NN	clinician
scientists	NNS	scientist
of	IN	of
a	DT	a
helminth	NN	helminth
.	SENT	.
reninangiotensin-aldosterone	NN	INFunknownSUP
system	NN	system
.	SENT	.
anti-scarring	JJ	INFunknownSUP
properties	NNS	property
.	SENT	.
marker	NN	marker
sVCAM-1	NN	INFunknownSUP
.	SENT	.
intensity	NN	intensity
of	IN	of
mast	NN	mast
cell	NN	cell
infiltration	NN	infiltration
.	SENT	.
A.Amyotrophic	JJ	INFunknownSUP
lateral	JJ	lateral
sclerosis	NN	sclerosis
.	SENT	.
CLEC9A-knocked	JJ	INFunknownSUP
down	JJ	down
cells	NNS	cell
.	SENT	.
down	JJ	down
cells	NNS	cell
.	SENT	.
pattern	NN	pattern
focal	JJ	focal
choroidal	JJ	INFunknownSUP
excavation	NN	excavation
transformation	NN	transformation
.	SENT	.
extent	NN	extent
of	IN	of
fibrosis	NN	fibrosis
.	SENT	.
polymerase	NN	polymerase
chain	NN	chain
reaction	NN	reaction
.	SENT	.
%	NN	%
diameter	NN	diameter
increase	NN	increase
.	SENT	.
total	JJ	total
body	NN	body
surface	NN	surface
area	NN	area
scald	NN	scald
burn	NN	burn
.	SENT	.
genetic	JJ	genetic
inheritance	NN	inheritance
.	SENT	.
higher	JJR	high
levels	NNS	level
of	IN	of
high-sensitivity	NN	INFunknownSUP
C-reactive	JJ	INFunknownSUP
protein	NN	protein
.	SENT	.
ischemic	JJ	ischemic
heart	NN	heart
disease	NN	disease
.	SENT	.
great	JJ	great
interest	NN	interest
.	SENT	.
Pathway	NP	INFunknownSUP
enrichment	NN	enrichment
analysis	NN	analysis
.	SENT	.
muscle	NN	muscle
cells	NNS	cell
.	SENT	.
response	NN	response
to	TO	to
heat-killed	JJ	INFunknownSUP
M.	NP	M.
tuberculosis	NN	tuberculosis
H37Ra	NP	INFunknownSUP
treatment	NN	treatment
.	SENT	.
histological	JJ	histological
analysis	NN	analysis
.	SENT	.
therapeutic	JJ	therapeutic
approaches	NNS	approach
.	SENT	.
biota	NN	biota
of	IN	of
the	DT	the
human	JJ	human
body	NN	body
.	SENT	.
INFLAMMATORY	NP	INFunknownSUP
CHOROIDAL	NP	INFunknownSUP
.	SENT	.
fecal	JJ	fecal
microbiome	NN	INFunknownSUP
.	SENT	.
non-IC	JJ	INFunknownSUP
cystitis	NN	cystitis
.	SENT	.
